Kozo Yoneda
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Kozo Yoneda has a total of 32 co-authors. Here are the top co-authors by number of shared publications:
Masayo Yamagata
Laboratory of Clinical Pharmacology, Faculty of Pharmacy, Osaka Ohtani University, Tondabayashi, Japan
4 shared publications- Takaomi Shimokawa
Laboratory of Clinical Pharmacology, Faculty of Pharmacy, Osaka Ohtani University, 3-11-1 Nishikiori-kita, Tondabayashi, Osaka, 584-8540, Japan
4 shared publications Kohei Hayashi
Laboratory of Clinical Pharmacology, Faculty of Pharmacy, Osaka Ohtani University, Tondabayashi, Japan
3 shared publications- Kozo Nakai
Department of Dermatology, Kagawa University, Kagawa, Japan
2 shared publications Shuhei Tomita
Department of Pharmacology, Osaka City University Graduate School of Medicine, Asahimachi, Abeno-ku, Osaka, 545-8585, Japan
2 shared publications- Takashi Hashimoto
Department of Dermatology Graduate School of Medicine, Osaka Metropolitan University Osaka Japan
2 shared publications
Latest Publications
- 27 November 2021
- Published by Springer Nature in Cell and tissue research
- Vol. 387 (2) , 303-314
Subcellular distribution of α2-adrenoceptor subtypes in the rodent kidney
Renal α2-adrenoceptors have been reported to play a role in the regulation of urinary output, renin secretion, and water and sodium excretion in the kidneys. However, the distribution of α2-adrenoceptor subtypes in the kidneys remains unclear. In this study, we aimed to investigate the localization of α2-adrenoceptor subtypes in rat kidneys using 8-week-old Sprague–Dawley rats. Immunofluorescence imaging revealed that both α2A- and α2B-adrenoceptors were expressed in the basolateral, but not apical, membrane of the epithelial cells of the proximal tubules. We also found that α2A- and α2B-adrenoceptors were not expressed in the glomeruli, collecting ducts, or the descending limb of the loop of Henle and vasa recta. In contrast, α2C-adrenoceptors were found to be localized in the glomeruli and lumen of the cortical and medullary collecting ducts. These results suggest that noradrenaline may act on the basement membrane of the proximal tubules through α2A- and α2B-adrenoceptors. Moreover, noradrenaline may be involved in the regulation of glomerular filtration and proteinuria through the induction of morphological changes in mesangial cells and podocytes via α2C-adrenoceptors. In the collecting ducts, urinary noradrenaline may regulate morphological changes of the microvilli through α2C-adrenoceptors. Our findings provide an immunohistochemical basis for understanding the cellular targets of α2-adrenergic regulation in the kidneys. This may be used to devise therapeutic strategies targeting α2-adrenoceptors.
- 27 November 2021
- Published by Springer Nature in Cell and tissue research
- Vol. 387 (2) , 303-314
Subcellular distribution of α2-adrenoceptor subtypes in the rodent kidney
Renal α2-adrenoceptors have been reported to play a role in the regulation of urinary output, renin secretion, and water and sodium excretion in the kidneys. However, the distribution of α2-adrenoceptor subtypes in the kidneys remains unclear. In this study, we aimed to investigate the localization of α2-adrenoceptor subtypes in rat kidneys using 8-week-old Sprague–Dawley rats. Immunofluorescence imaging revealed that both α2A- and α2B-adrenoceptors were expressed in the basolateral, but not apical, membrane of the epithelial cells of the proximal tubules. We also found that α2A- and α2B-adrenoceptors were not expressed in the glomeruli, collecting ducts, or the descending limb of the loop of Henle and vasa recta. In contrast, α2C-adrenoceptors were found to be localized in the glomeruli and lumen of the cortical and medullary collecting ducts. These results suggest that noradrenaline may act on the basement membrane of the proximal tubules through α2A- and α2B-adrenoceptors. Moreover, noradrenaline may be involved in the regulation of glomerular filtration and proteinuria through the induction of morphological changes in mesangial cells and podocytes via α2C-adrenoceptors. In the collecting ducts, urinary noradrenaline may regulate morphological changes of the microvilli through α2C-adrenoceptors. Our findings provide an immunohistochemical basis for understanding the cellular targets of α2-adrenergic regulation in the kidneys. This may be used to devise therapeutic strategies targeting α2-adrenoceptors.
- Open Access
- 13 June 2021
- Published by Wiley in The Journal of Dermatology
- Vol. 48 (8) , E353-E367
Japanese guidelines for the management of palmoplantar keratoderma
Palmoplantar keratoderma (PPK) is a collective term for keratinizing disorders in which the main clinical symptom is hyperkeratosis on the palms and soles. To establish the first Japanese guidelines approved by the Japanese Dermatological Association for the management of PPKs, the Committee for the Management of PPKs was founded as part of the Study Group for Rare Intractable Diseases. These guidelines aim to provide current information for the management of PPKs in Japan. Based on evidence, they summarize the clinical manifestations, pathophysiologies, diagnostic criteria, disease severity determination criteria, treatment, and treatment recommendations. Because of the rarity of PPKs, there are only few clinical studies with a high degree of evidence. Therefore, several parts of these guidelines were established based on the opinions of the committee. To further optimize the guidelines, periodic revision in line with new evidence is necessary.
- 13 June 2021
- Published by Wiley in The Journal of Dermatology
- Vol. 48 (8) , E353-E367
Open AccessJapanese guidelines for the management of palmoplantar keratoderma
Palmoplantar keratoderma (PPK) is a collective term for keratinizing disorders in which the main clinical symptom is hyperkeratosis on the palms and soles. To establish the first Japanese guidelines approved by the Japanese Dermatological Association for the management of PPKs, the Committee for the Management of PPKs was founded as part of the Study Group for Rare Intractable Diseases. These guidelines aim to provide current information for the management of PPKs in Japan. Based on evidence, they summarize the clinical manifestations, pathophysiologies, diagnostic criteria, disease severity determination criteria, treatment, and treatment recommendations. Because of the rarity of PPKs, there are only few clinical studies with a high degree of evidence. Therefore, several parts of these guidelines were established based on the opinions of the committee. To further optimize the guidelines, periodic revision in line with new evidence is necessary.
- Open Access
- 1 January 2021
- Published by Elsevier in Journal of Pharmacological Sciences
- Vol. 145 (1) , 79-87
Inhibition of α2-adrenoceptor is renoprotective in 5/6 nephrectomy-induced chronic kidney injury rats
- 1 January 2021
- Published by Elsevier in Journal of Pharmacological Sciences
- Vol. 145 (1) , 79-87
Open AccessInhibition of α2-adrenoceptor is renoprotective in 5/6 nephrectomy-induced chronic kidney injury rats
- 1 March 2020
- Published by Elsevier in European Journal of Pharmacology
- Vol. 871, 172917
Yohimbine ameliorates lipopolysaccharide-induced acute kidney injury in rats
- 1 March 2020
- Published by Elsevier in European Journal of Pharmacology
- Vol. 871, 172917
Yohimbine ameliorates lipopolysaccharide-induced acute kidney injury in rats
- Open Access
- 1 January 2020
- Published by Japanese Pharmacological Society in Proceedings for Annual Meeting of The Japanese Pharmacological Society
- Vol. 93, 2-200
Yohimbine ameliorates lipopolysaccharide-induced acute kidney injury in rats
Sepsis-induced acute kidney injury (AKI) is frequently observed in the intensive care unit. We previously revealed that yohimbine, α2-adrenoceptor antagonist, has protective effect against renal ischemia/reperfusion injury-induced AKI in rats. This study aimed to investigate the renoprotective effect of yohimbine against lipopolysaccharide (LPS) - induced AKI in rats. Male Sprague Dawley rats were randomly divided into following groups: Sham-operated group, LPS (10 mg/kg, i.p.), LPS + yohimbine (0.1 or 0.5 mg/kg, i.p.). Kidney functional parameters of blood urea nitrogen (BUN), plasma creatinine (Pcr) were aggravated in LPS group. Administration of LPS decreased mean arterial blood pressure. In addition, kidney injury molecule-1, iNOS and various cytokine expression such as TNF-α, MCP-1 and IL-6 were increased by LPS administration. The treatment with yohimbine clearly ameliorated damaged kidney function and blood pressure due to LPS. Moreover, yohimbine suppressed cytokine mRNA and iNOS expression enhanced by LPS. However, anti-inflammatory cytokine IL-10 mRNA levels were augmented by yohimbine. NF-kB nuclear translocation in kidney was observed 1 hr after injection of LPS in rats. Yohimbine blocked nuclear entry of NF-kB. In addition, phosphorylation of ERK and CREB were enhanced with yohimbine. These results suggest that yohimbine can prevent LPS-induced sepsis associated with kidney injury by suppressing the inflammatory cytokine expression and enhancement of IL-10 expression via ERK/CREB phosphorylation.
- 1 January 2020
- Published by Japanese Pharmacological Society in Proceedings for Annual Meeting of The Japanese Pharmacological Society
- Vol. 93, 2-200
Open AccessYohimbine ameliorates lipopolysaccharide-induced acute kidney injury in rats
Sepsis-induced acute kidney injury (AKI) is frequently observed in the intensive care unit. We previously revealed that yohimbine, α2-adrenoceptor antagonist, has protective effect against renal ischemia/reperfusion injury-induced AKI in rats. This study aimed to investigate the renoprotective effect of yohimbine against lipopolysaccharide (LPS) - induced AKI in rats. Male Sprague Dawley rats were randomly divided into following groups: Sham-operated group, LPS (10 mg/kg, i.p.), LPS + yohimbine (0.1 or 0.5 mg/kg, i.p.). Kidney functional parameters of blood urea nitrogen (BUN), plasma creatinine (Pcr) were aggravated in LPS group. Administration of LPS decreased mean arterial blood pressure. In addition, kidney injury molecule-1, iNOS and various cytokine expression such as TNF-α, MCP-1 and IL-6 were increased by LPS administration. The treatment with yohimbine clearly ameliorated damaged kidney function and blood pressure due to LPS. Moreover, yohimbine suppressed cytokine mRNA and iNOS expression enhanced by LPS. However, anti-inflammatory cytokine IL-10 mRNA levels were augmented by yohimbine. NF-kB nuclear translocation in kidney was observed 1 hr after injection of LPS in rats. Yohimbine blocked nuclear entry of NF-kB. In addition, phosphorylation of ERK and CREB were enhanced with yohimbine. These results suggest that yohimbine can prevent LPS-induced sepsis associated with kidney injury by suppressing the inflammatory cytokine expression and enhancement of IL-10 expression via ERK/CREB phosphorylation.
- 14 July 2011
- Published by Taylor & Francis in Journal of Dermatological Treatment
- Vol. 23 (3) , 172-176
Combination effects of cosmetic moisturisers in the topical treatment of acne vulgaris
Cosmetic moisturisers were applied to one side of the face of 18 male Japanese patients with acne vulgaris who were treated with a topical administration of adapalene and clindamycin phosphate gels. We assessed the alleviating effect of the moisturisers on the side effects of the treatment. The severity of acne and the number of inflammatory and non-inflammatory lesions were measured at 0, 2, and 4 weeks. The water content in the stratum corneum and transepidermal water loss were measured by comparing the moisturiser-treated and untreated sides of the face. The sensation of skin dryness and irritation on both sides of the face were assessed by the subjects. We observed that the use of moisturisers did not impact the efficacy of the standard topical treatment and they significantly improved the water content in the stratum corneum and the sensation of dryness. These results suggested that the use of moisturisers in combination with the standard topical treatment may improve adherence to therapy by alleviating the sensation of dryness.
- 14 July 2011
- Published by Taylor & Francis in Journal of Dermatological Treatment
- Vol. 23 (3) , 172-176
Combination effects of cosmetic moisturisers in the topical treatment of acne vulgaris
Cosmetic moisturisers were applied to one side of the face of 18 male Japanese patients with acne vulgaris who were treated with a topical administration of adapalene and clindamycin phosphate gels. We assessed the alleviating effect of the moisturisers on the side effects of the treatment. The severity of acne and the number of inflammatory and non-inflammatory lesions were measured at 0, 2, and 4 weeks. The water content in the stratum corneum and transepidermal water loss were measured by comparing the moisturiser-treated and untreated sides of the face. The sensation of skin dryness and irritation on both sides of the face were assessed by the subjects. We observed that the use of moisturisers did not impact the efficacy of the standard topical treatment and they significantly improved the water content in the stratum corneum and the sensation of dryness. These results suggested that the use of moisturisers in combination with the standard topical treatment may improve adherence to therapy by alleviating the sensation of dryness.
- Open Access
- 1 May 2010
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 285 (21) , 16184-16194
Activation of Vascular Endothelial Growth Factor Receptor 2 in a Cellular Model of Loricrin Keratoderma
- 1 May 2010
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 285 (21) , 16184-16194
Open AccessActivation of Vascular Endothelial Growth Factor Receptor 2 in a Cellular Model of Loricrin Keratoderma